GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male mice

Journal of Bone and Mineral Research

Volumn 26, Issue 2, 2011, Pages 298-307

  Ford, Jeffery ^a   Hajibeigi, Asghar ^a   Long, Michael ^a   Hahner, Lisa ^b   Gore, Crystal ^a   Hsieh, Jer Tseng ^a   Clegg, Deborah ^b   Zerwekh, Joseph ^b   Öz, Orhan K ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

BONE; BONE DENSITY; GPR30; GROWTH PLATE; OSTEOBLAST

Indexed keywords

ALKALINE PHOSPHATASE; BROXURIDINE; G PROTEIN COUPLED RECEPTOR 30; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY SIZE; BONE DENSITY; BONE MARROW CELL; BONE MASS; BONE MINERALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; GROWTH PLATE; KNOCKOUT MOUSE; LEAN BODY WEIGHT; MALE; MOUSE; NONHUMAN; PROTEIN DEFICIENCY; WILD TYPE;

ABSORPTIOMETRY, PHOTON; ALKALINE PHOSPHATASE; ANIMALS; BONE AND BONES; BONE MARROW CELLS; BROMODEOXYURIDINE; DENSITOMETRY; ESTROGENS; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, KNOCKOUT; MUTATION; OSTEOBLASTS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 79251498314     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.209     Document Type: Article

References (51)

1. Carani C, Qin K, Simoni M, et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med. 1997; 337: 91-95.
2. Bulun SE., Clinical review 78: Aromatase deficiency in women and men: would you have predicted the phenotypes ? J Clin Endocrinol Metab. 1996; 81: 867-871.
3. Simpson ER., Genetic mutations resulting in loss of aromatase activity in humans and mice. J Soc Gynecol Invest. 2000; 7: S18-21.
4. Bilezikian JP, Morishima A, Bell J, Grumbach MM., Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med. 1998; 339: 599-603.
5. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K., Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab. 1995; 80: 3689-3698.
6. Maffei L, Murata Y, Rochira V, et al. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab. 2004; 89: 61-70.
7. Herrmann BL, Saller B, Janssen OE, et al. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J Clin Endocrinol Metab. 2002; 87: 5476-5484.
8. Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994; 331: 1056-1061.
9. Oz OK, Zerwekh JE, Fisher C, et al. Bone has a sexually dimorphic response to aromatase deficiency. J Bone Miner Res. 2000; 15: 507-514.
10. Oz OK, Hirasawa G, Lawson J, et al. Bone phenotype of the aromatase deficient mouse. J Steroid Biochem Mol Biol. 2001; 79: 49-59.
11. Sims NA, Dupont S, Krust A, et al. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone. 2002; 30: 18-25.
12. Thomas P, Pang Y, Filardo EJ, Dong J., Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology. 2005; 146: 624-632.
13. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER., A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005; 307: 1625-1630.
14. Feng Y, Gregor P., Cloning of a novel member of the G protein-coupled receptor family related to peptide receptors. Biochem Biophys Res Commun. 1997; 231: 651-654.
15. ODowd BF, Nguyen T, Marchese A, et al. Discovery of three novel G-protein-coupled receptor genes. Genomics. 1998; 47: 310-313.
16. Carmeci C, Thompson DA, Ring HZ, Francke U, Weigel RJ., Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics. 1997; 45: 607-617.
17. Takada Y, Kato C, Kondo S, Korenaga R, Ando J., Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress. Biochem Biophys Res Commun. 1997; 240: 737-741.
18. Owman C, Blay P, Nilsson C, Lolait SJ., Cloning of human cDNA encoding a novel heptahelix receptor expressed in Burkitts lymphoma and widely distributed in brain and peripheral tissues. Biochem Biophys Res Commun. 1996; 228: 285-292.
19. Bologa CG, Revankar CM, Young SM, et al. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol. 2006; 2: 207-212.
20. Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI., Estrogen action via the G protein-coupled receptor, GP R30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol. 2002; 16: 70-84.
21. Filardo E, Quinn J, Pang Y, et al. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology. 2007; 148: 3236-3245.
22. Funakoshi T, Yanai A, Shinoda K, Kawano MM, Mizukami Y., G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem Biophys Res Commun. 2006; 346: 904-910.
23. Revankar CM, Mitchell HD, Field AS, et al. Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30. ACS Chem Biol. 2007; 2: 536-544.
24. Kamanga-Sollo E, White ME, Chung KY, Johnson BJ, Dayton WR., Potential role of G-protein-coupled receptor 30 (GPR30) in estradiol-17beta-stimulated IGF-I mRNA expression in bovine satellite cell cultures. Domest Anim Endocrinol. 2008; 35: 254-262.
25. Sakamoto H, Matsuda K, Hosokawa K, et al. Expression of G protein-coupled receptor-30, a G protein-coupled membrane estrogen receptor, in oxytocin neurons of the rat paraventricular and supraoptic nuclei. Endocrinology. 2007; 148: 5842-5850.
26. Chagin AS, Sävendahl L., GPR30 estrogen receptor expression in the growth plate declines as puberty progresses. J Clin Endocrinol Metab. 2007; 92: 4873-4877.
27. Heino TJ, Chagin AS, Savendahl L., The novel estrogen receptor G-protein-coupled receptor 30 is expressed in human bone. J Endocrinol. 2008; 197: R1-6.
28. Teplyuk NM, Galindo M, Teplyuk VI, et al. Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors. J Biol Chem. 2008; 283: 27585-27597.
29. Wang C, Dehghani B, Magrisso IJ, et al. GPR30 contributes to estrogen-induced thymic atrophy. Mol Endocrinol. 2008; 22: 636-648.
30. Isensee J, Meoli L, Zazzu V, et al. Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice. Endocrinology. 2009; 150: 1722-1723.
31. Otto C, Fuchs I, Kauselmann G, et al. GPR30 does not mediate estrogenic responses in reproductive organs in mice. Biol Reprod. 2009; 80: 34-41.
32. Martensson UE, Salehi SA, Windahl S, et al. Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology. 2009; 150: 687-698.
33. Windahl SH, Andersson N, Chagin AS, et al. The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice. Am J Physiol Endocrinol Metab. 2009; 296: E490-6.
34. Barou O, Laroche N, Palle S, Alexandre C, Lafage-Proust MH., Pre-osteoblastic proliferation assessed with BrdU in undecalcified, Epon-embedded adult rat trabecular bone. J Histochem Cytochem. 1997; 45: 1189-1195.
35. Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CY., Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria. Osteoporos Int. 1992; 2: 128-134.
36. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987; 2: 595-610.
37. Hahn M, Vogel M, Pompesius-Kempa M, Delling G., Trabecular bone pattern factor-a new parameter for simple quantification of bone microarchitecture. Bone. 1992; 13: 327-330.
38. Haas E, Bhattacharya I, Brailoiu E, et al. Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res. 2009; 104: 288-291.
39. Davey RA, MacLean HE, McManus JF, Findlay DM, Zajac JD., Genetically modified animal models as tools for studying bone and mineral metabolism. J Bone Miner Res. 2004; 19: 882-892.
40. Jenei-Lanzl Z, Straub RH, Dienstknecht T, et al. Estradiol inhibits chondrogenic differentiation of mesenchymal stem cells via non-classical signalling. Arthritis Rheum. 2010; 62: 1088-1096.
41. Schmidt EE, Taylor DS, Prigge JR, Barnett S, Capecchi MR., Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids. Proc Natl Acad Sci U S A. 2000; 97: 13702-13707.
42. Grumbach MM., Mutations in the synthesis and action of estrogen: the critical role in the male of estrogen on pubertal growth, skeletal maturation, and bone mass. Ann N Y Acad Sci. 2004; 1038: 7-13.
43. Rochira V, Carani C., Aromatase deficiency in men: a clinical perspective. Nat Rev Endocrinol. 2009; 5: 559-568.
44. Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, Hathaway HJ., Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Ann Rev Physiol. 2008; 70: 165-190.
45. Vidal O, Lindberg MK, Hollberg K, et al. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc Natl Acad Sci U S A. 2000; 97: 5474-549.
46. Sims NA, Brennan K, Spaliviero J, Handelsman DJ, Seibel MJ., Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling. Am J Physiol Endocrinol Metab. 2006; 290: E456-62.
47. Ariazi EA, Brailoiu E, Yerrum S, et al. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. Cancer Res. 2010; 70: 1184-1194.
48. Reid IR., Relationships among body mass, its components, and bone. Bone. 2002; 31: 547-555.
49. Duncan RL, Turner CH., Mechanotransduction and the functional response of bone to mechanical strain. Calcif Tissue Int. 1995; 57: 344-358.
50. Prossnitz ER, Maggiolini M., Mechanisms of estrogen signaling and gene expression via GPR30. Mol Cell Endocrinol. 2009; 308: 32-38.
51. Maggiolini M, Picard D., The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol. 2010; 204: 105-114.